Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0
Sign in

SRR598533

GTEX

2abb38ae-b0a7-5cbe-a188-1027879cf361

Score in workbench →

Clinical attributes

From the source cohort, normalized into canonical keys plus the project's native columns.

cancer_type
GTEX
cancer_type_detailed
subtype
cancer_type
GTEX
sex
Female

GSVA pathway preview (50 Hallmark scores)

MeasuredDerivedReference

Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.

Top 10 elevated

  • KRAS_SIGNALING_DN+0.339
  • ALLOGRAFT_REJECTION+0.190
  • SPERMATOGENESIS+0.171
  • PANCREAS_BETA_CELLS+0.094
  • MYOGENESIS-0.033
  • IL6_JAK_STAT3_SIGNALING-0.038
  • APICAL_SURFACE-0.042
  • APICAL_JUNCTION-0.072
  • INFLAMMATORY_RESPONSE-0.077
  • E2F_TARGETS-0.101

Top 10 suppressed

  • OXIDATIVE_PHOSPHORYLATION-0.614
  • ADIPOGENESIS-0.516
  • TGF_BETA_SIGNALING-0.511
  • FATTY_ACID_METABOLISM-0.480
  • REACTIVE_OXYGEN_SPECIES_PATHWAY-0.475
  • MYC_TARGETS_V1-0.458
  • NOTCH_SIGNALING-0.457
  • MTORC1_SIGNALING-0.455
  • CHOLESTEROL_HOMEOSTASIS-0.451
  • HEDGEHOG_SIGNALING-0.438

Patient twins — nearest pathway neighbors

MeasuredDerived

10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.

10 twins match this tumor's tissue · 0 come from a different tissue of origin

#SampleCancer typeSubtypecos similarity
1SRR602753
brain-umap@2
GTEX0.972
2SRR1452056
brain-umap@2
GTEX0.961
3SRR1439674
brain-umap@2
GTEX0.952
4SRR1485789
brain-umap@2
GTEX0.952
5SRR1471374
brain-umap@2
GTEX0.937
6SRR1435884
brain-umap@2
GTEX0.928
7SRR1479912
brain-umap@2
GTEX0.927
8MNG555
mng-umap@100
0.925
9SRR627425
brain-umap@2
GTEX0.925
10SRR8942981
bladder-landscape@3
0.919

Per-pathway drug coverage

ModeledCalibratedDerived

For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.

0 of 4 elevated pathways have at least one drug that meaningfully reverses them.

Pathway (elevated)tumor scoreBest drugreversal magnitude
KRAS_SIGNALING_DN0.339Remibrutinib— uncovered
ALLOGRAFT_REJECTION0.190Idelalisib— uncovered
SPERMATOGENESIS0.171Inavolisib— uncovered
PANCREAS_BETA_CELLS0.094Cobimetinib— uncovered